Last quarter (Q4 2022), Shanghai Pharmaceuticals Holding Co's total revenue was ¥57.37B, an increase of 4.59% from the same quarter last year. In Q4, Shanghai Pharmaceuticals Holding Co's net income was ¥803.25M. See Shanghai Pharmaceuticals Holding Co’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	¥ 231.98B	¥ 231.98B	¥ 215.82B	¥ 191.91B	¥ 186.57B	¥ 159.08B
Cost of Revenue	¥ 201.49B	¥ 201.49B	¥ 187.28B	¥ 165.18B	¥ 159.75B	¥ 136.52B
Gross Profit	¥ 30.49B	¥ 30.49B	¥ 28.54B	¥ 26.73B	¥ 26.81B	¥ 22.56B
Operating Expense	¥ 21.71B	¥ 21.71B	¥ 20.62B	¥ 18.59B	¥ 18.88B	¥ 16.33B
Operating Income	¥ 8.78B	¥ 8.78B	¥ 7.93B	¥ 8.14B	¥ 6.76B	¥ 6.24B
Net Non Operating Interest Income Expense	¥ -1.33B	¥ -1.33B	¥ -1.26B	¥ -1.20B	¥ -1.24B	¥ -1.11B
Other Income Expense	-	-	-	-	-	-
Pretax Income	¥ 8.81B	¥ 8.81B	¥ 8.14B	¥ 7.18B	¥ 6.26B	¥ 5.34B
Tax Provision	¥ 1.82B	¥ 1.82B	¥ 1.87B	¥ 1.57B	¥ 1.43B	¥ 887.12M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	¥ 5.62B	¥ 5.62B	¥ 5.09B	¥ 4.50B	¥ 4.08B	¥ 3.88B
Basic EPS	¥ 1.61	¥ 1.61	¥ 1.79	¥ 1.58	¥ 1.44	¥ 1.37
Diluted EPS	¥ 1.61	¥ 1.61	¥ 1.79	¥ 1.58	¥ 1.44	¥ 1.37
Basic Average Shares	¥ 13.96B	¥ 3.49B	¥ 2.85B	¥ 2.85B	¥ 2.83B	¥ 2.83B
Diluted Average Shares	¥ 13.96B	¥ 3.49B	¥ 2.85B	¥ 2.85B	¥ 2.83B	¥ 2.83B
Dividend Per Share	¥ 0.42	¥ 0.42	¥ 0.48	¥ 0.44	¥ 0.41	¥ 0.00
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	¥ 1.23	¥ 1.41	¥ 1.34	¥ 1.22	¥ 0.94
Reported Normalized Diluted E P S	-	¥ 1.23	¥ 1.41	¥ 1.34	¥ 1.22	¥ 0.94
Rent Expense Supplemental	-	¥ 74.65M	¥ 91.43M	¥ 48.20M	¥ 25.77M	¥ 231.67M
Total Expenses	¥ 223.20B	¥ 223.20B	¥ 207.90B	¥ 183.77B	¥ 178.64B	¥ 152.85B
Net Income From Continuing And Discontinued Operation	¥ 5.62B	¥ 5.62B	¥ 5.09B	¥ 4.50B	¥ 4.08B	¥ 3.88B
Normalized Income	¥ 5.02B	¥ 5.05B	¥ 5.22B	¥ 4.50B	¥ 3.04B	¥ 4.81B
Interest Expense	¥ 1.69B	¥ 1.69B	¥ 1.52B	¥ 1.41B	¥ 1.41B	¥ 1.20B
EBIT	¥ 10.50B	¥ 10.50B	¥ 9.66B	¥ 8.59B	¥ 7.67B	¥ 6.55B
EBITDA	¥ 10.50B	¥ 12.72B	¥ 11.80B	¥ 9.70B	¥ 9.55B	¥ 7.71B

Currency in CNY

Shanghai Pharmaceuticals Holding Co Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing